The ARF tumor suppressor: structure, functions and status in cancer.
about
Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21Novel Molecular Markers for Breast CancerPatterns of Chromosomal Aberrations in Solid TumorsRoles of N-Myc and STAT interactor in cancer: From initiation to disseminationChimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiencyEvaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myelomaThe rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16 (INK4a) ExpressionGene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor LineagesGLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARFDeciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARFThe role of MDM2 and MDM4 in breast cancer development and prevention.Haploinsufficient tumor suppressor genes.p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B.PIWIL4 regulates cervical cancer cell line growth and is involved in down-regulating the expression of p14ARF and p53.Efficient introduction of specific TP53 mutations into mouse embryonic fibroblasts and embryonic stem cells.Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53.Genetic variation in MDM2 and p14ARF and susceptibility to salivary gland carcinoma.Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomasA p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosisHuman cancer-associated mutations in the Aα subunit of protein phosphatase 2A increase lung cancer incidence in Aα knock-in and knockout mice.A rapid and scalable system for studying gene function in mice using conditional RNA interference.Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.Clinicopathological and Targeted Exome Gene Features of a Patient with Metastatic Acinic Cell Carcinoma of the Parotid Gland Harboring an ARID2 Nonsense Mutation and CDKN2A/B Deletion.Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerWhole Chromosome Instability induces senescence and promotes SASP.Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.FMN2 is a novel regulator of the cyclin-dependent kinase inhibitor p21.Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma.All-trans retinoic acid and genistein induce cell apoptosis in OVCAR-3 cells by increasing the P14 tumor suppressor gene.Suppression of GNAI2 message in ovarian cancer.Aberrant expression of cyclin D1 in cancer.Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.The tumor suppressor role of CTCF.Transcription factors that interact with p53 and Mdm2ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis
P2860
Q24313202-F94C8485-EB90-46D5-862E-BB1384C14011Q26753160-9A6D5E2A-7B6F-4FD5-9974-52988A809A47Q26786127-165C0249-4A9F-443B-A558-F2B579728184Q28077896-B9A3E10F-7704-48D7-AAEF-B76D69CA0689Q28290365-A7EF84E4-B99E-4A19-8E21-6633FFC9DA78Q28296718-5CD38914-D27F-4D6F-9766-FD04831D3A46Q28384613-143083E8-1E52-412D-AB06-0431321F111CQ28548165-9F9C9D3C-FF61-4CC9-9C7B-377F503D7299Q30032677-BB3BCA7C-6C49-4768-9E5D-2A49D5024A3AQ30536268-BF21502B-73D0-4CAC-8152-BED6F7D3F74DQ33567807-FE9CA73C-040C-4B0B-8477-87DCB2154BAEQ33712095-A06E481A-E396-4C96-99B3-37AD5389CC02Q33864922-9154B86D-EE9A-42BA-8D59-7427B3E6C96BQ34166041-A25E7C38-CD4F-40D0-B694-AAD36B70712AQ34166850-A79CD87B-F5E2-4321-B8A7-3B39351C6189Q34266578-31A7157D-F668-429D-965C-6A91A9DF5638Q34273072-69475BF9-6B6E-4EB5-9EAA-73E8ABD5F2F1Q34430887-071D75C9-4B9A-4275-BEC1-E2DF244E4C43Q34474451-AD3FD9E8-84B4-4102-AC81-C83A0ACD63F2Q34545274-B384967F-2B96-4CF0-9EBE-9C681493C800Q35067979-5CA166BA-D5A3-4B80-87A7-F5A2125E371AQ35108867-1A98E357-4130-459C-817A-9B9081A64FCDQ35192607-1743145C-2022-4AA2-AB78-42B17CE15C72Q35627849-93CBBDA6-DCB6-4623-AB7F-9FCFB1D38094Q35859963-31AEA4FA-B6F0-407C-90A9-903C808A9A41Q36304519-A16E0CF6-8206-4C16-AF24-B7A7092E27E5Q36724434-E13248C1-BD0A-42BE-BA26-FEB7944765A6Q37306546-62830A39-E6D9-48D9-90D5-417D595C8954Q37330587-78DD0582-5F19-4334-B357-7AED115B7BC9Q37344073-C2BD61BC-B549-470B-92E9-F182D991457AQ37344768-E06C13A5-A22C-43E5-93B5-FC00E5DA9B57Q37482664-E18C7979-929C-4EBA-A381-1E6CE7EEB827Q37517664-3C7B18E2-CFE6-4E3A-A475-465A8403464FQ37526611-D28881E5-F3D2-41CC-A0FC-AD0A98471048Q37580471-58C561C8-BAD5-4A1E-8FFC-8676C8AC3970Q37649642-4F3760D8-DE47-4C2F-8F92-7BC7546BE8CBQ37861625-84F43412-918B-4484-B04D-E5489497E9B5Q38541481-18E55886-F96A-49B2-9927-9E1CB87EAF77Q38692678-8C91C404-62A1-47A2-B1BA-BCF43D33134DQ38784576-5B753D40-3E22-4834-8634-AC2C9EFD3532
P2860
The ARF tumor suppressor: structure, functions and status in cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The ARF tumor suppressor: structure, functions and status in cancer.
@en
The ARF tumor suppressor: structure, functions and status in cancer.
@nl
type
label
The ARF tumor suppressor: structure, functions and status in cancer.
@en
The ARF tumor suppressor: structure, functions and status in cancer.
@nl
prefLabel
The ARF tumor suppressor: structure, functions and status in cancer.
@en
The ARF tumor suppressor: structure, functions and status in cancer.
@nl
P2093
P2860
P356
P1476
The ARF tumor suppressor: structure, functions and status in cancer.
@en
P2093
Beatrice Eymin
Peggy Ozenne
Sylvie Gazzeri
P2860
P304
P356
10.1002/IJC.25511
P577
2010-11-01T00:00:00Z